“…Mouse keratinocytes were isolated from the skin of newborn ICR CD1 mice and cultured as described previously [ 63 ], according to protocols approved by the Institutional Care and Use Committees of Augusta University (Protocol #2017-0915) and the Charlie Norwood VA Medical Center (Protocol #22-04-135). Keratinocytes were treated with 0, 2.0 µg/mL LPS (Sigma-Aldrich, St. Louis, MO, USA), or 2.5 µg/mL Pam 3 CSK 4 (EMD Millipore Corporation, Burlington, MA, USA) in the presence or absence of 1 µM SAHA (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C with 5% CO 2 for 24 h; or with 0, 50, or 100 µg/mL AGE-BSA (Sigma-Aldrich or BioVision Incorporated, Milpitas, CA, USA), in the presence or absence of 1 or 2 µM SAHA (based on our previous studies [ 40 ]) at 37 °C with 5% CO 2 for 24, 48, and 72 h. Doses of AGEs were selected based on previous literature [ 54 , 64 , 65 , 66 ].…”